Publications by authors named "Gregor Timlin"

Article Synopsis
  • - This observational study evaluated the use of a smartphone app for monitoring blood pressure (BP) and COVID-19 symptoms during the pandemic, focusing on its feasibility and safety.
  • - The study involved 389 participants who used the app over 12 weeks to track their BP, medication use, and COVID-related symptoms, assessing usability and user experience with standard surveys.
  • - Results showed a high engagement rate, with 98% of participants successfully downloading and entering their BP data, indicating the app's potential for practical health monitoring.
View Article and Find Full Text PDF

Background: The objective of the PERSONAL-CovidBP (Personalised Electronic Record Supported Optimisation When Alone for Patients With Hypertension: Pilot Study for Remote Medical Management of Hypertension During the COVID-19 Pandemic) trial was to assess the efficacy and safety of smartphone-enabled remote precision dosing of amlodipine to control blood pressure (BP) in participants with primary hypertension during the COVID-19 pandemic.

Methods And Results: This was an open-label, remote, dose titration trial using daily home self-monitoring of BP, drug dose, and side effects with linked smartphone app and telemonitoring. Participants aged ≥18 years with uncontrolled hypertension (5-7 day baseline mean ≥135 mm Hg systolic BP or ≥85 mm Hg diastolic BP) received personalized amlodipine dose titration using novel (1, 2, 3, 4, 6, 7, 8, 9 mg) and standard (5 and 10 mg) doses daily over 14 weeks.

View Article and Find Full Text PDF